Loading...
Topical co‐administration of zoledronate with recombinant human bone morphogenetic protein-2 can induce and maintain bone formation in the bone marrow environment
BACKGROUND: Bone morphogenetic proteins (BMPs) induce osteogenesis in various environments. However, when BMPs are used alone in the bone marrow environment, the maintenance of new bone formation is difficult owing to vigorous bone resorption. This is because BMPs stimulate the differentiation of no...
Saved in:
Published in: | BMC Musculoskelet Disord |
---|---|
Main Authors: | , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
BioMed Central
2021
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7819170/ https://ncbi.nlm.nih.gov/pubmed/33472600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-021-03971-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|